Mirati Therapeutics reported $-183589000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US $ -98.67M 3.96M
Alnylam Pharmaceuticals ALNY:US $ -137.27M 45.91M
Amgen AMGN:US $ 3341M 185M
Astellas Pharma 4503:JP Y 8836M 84655M
AstraZeneca AZN:LN 4187M 687M
Biocryst Pharmaceuticals BCRX:US $ -49.64M 2.37M
Bristol Myers Squibb BMY:US $ 5772M 404M
Eisai 4523:JP Y -11598M 35133M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Exelixis EXEL:US $ 87.73M 30.84M
Gilead Sciences GILD:US $ 3422M 1947M
GlaxoSmithKline GSK:LN 3120M 1062M
Johnson & Johnson JNJ:US $ 9309M 1549M
Merk MRK:US $ 6179M 492M
Moderna Inc MRNA:US 4.31B 1.18B
Nektar Therapeutics NKTR:US $ -111.36M 1.88M
Novartis NOVN:VX SF 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Puma Biotechnology PBYI:US $ 1.52M 7.59M
Sarepta Therapeutics SRPT:US $ -76.16M 19.51M
Seattle Genetics SGEN:US $ -115.96M 37.85M
Spectrum Pharmaceuticals SPPI:US $ -13.99M 22.79M
Takeda 4502:JP Y 150655M 139878M
Ultragenyx Pharmaceutical RARE:US $ -132.54M 33.51M
YTE INCY:US $ 144.1M 9.29M